New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function of a protein currently limited in clinical trials for cancer treatments.
Morning Overview on MSN
DNA-based system targets cancer cells by sensing 2 biomarkers
Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...
Most of our genome is often written off as “junk DNA”, meaning it doesn’t encode for genes that get made into proteins. This so-called junk consists of accumulated DNA elements like viral DNA that got ...
“[...] the biological mechanisms linking aging and osteoarthritis prevalence remain largely unknown.” “In this study, we use irradiation as an acute model of ...
Morning Overview on MSN
Study: Inflammation overwhelms DNA repair in some neurons in multiple sclerosis
Researchers have identified a specific class of brain neurons that dies during multiple sclerosis because inflammation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results